Advertisement
Advertisement
PACS
PACS Group, Inc.
49.44
USDSponsored
-0.16
-0.33%
Nov 09, 13:04 UTC -5
Open
PACS Group, Inc. (PACS) Earnings
PACS Earnings Reports
Positive Surprise Ratio
PACS beat 8 of 11 last estimates.
73%
Next Report
Date of Next Report
Feb 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
$1.61B
/$0.65
Implied change from Q3 26 (Revenue/ EPS)
+7.73%
/+3.17%
Implied change from Q4 25 (Revenue/ EPS)
+18.88%
/-5.80%
PACS Group, Inc. earnings per share and revenue
On Nov 03, 2026, PACS reported earnings of 0.63 USD per share (EPS) for Q3 26, beating the estimate of 0.59 USD, resulting in a 5.04% surprise. Revenue reached 1.50 billion, compared to an expected 1.49 billion, with a 0.68% difference. The market reacted with a +7.67% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.65 USD, with revenue projected to reach 1.61 billion USD, implying an increase of 3.17% EPS, and increase of 7.73% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Concentra Group Holdings Parent, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.44
Actual
$0.52
Surprise
+16.88%
Natera, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.29
Actual
-$0.42
Surprise
-40.70%
Viatris Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.64
Actual
$0.71
Surprise
+9.31%
Solventum Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.38
Actual
$1.45
Surprise
+5.02%
Sonida Senior Living, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.54
Actual
-$0.72
Surprise
-31.94%
Nutex Health Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$5.82
Actual
$5.71
Surprise
-1.93%
CryoPort, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.25
Surprise
-38.97%
Shoulder Innovations, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.34
Surprise
+32.57%
SkinHealth Systems Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.14
Surprise
+89.28%
Biodesix, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.76
Actual
-$0.75
Surprise
+1.77%
FAQ
What were PACS Group, Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, PACS Group, Inc. reported EPS of $0.63, beating estimates by 5.04%, and revenue of $1.50B, 0.68% above expectations.
How did the market react to PACS Group, Inc.'s Q3 2026 earnings?
The stock price moved up 7.67%, changed from $46.68 before the earnings release to $50.26 the day after.
When is PACS Group, Inc. expected to report next?
The next earning report is scheduled for Feb 24, 2027.
What are the forecasts for PACS Group, Inc.'s next earnings report?
Based on --
analysts, PACS Group, Inc. is expected to report EPS of $0.65 and revenue of $1.61B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.